Spectral Medical Inc.
EDTXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | 43.1% | -4.1% | -18.8% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $1 |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 44.5% | 41.4% | 59% | 59.5% |
| R&D Expenses | $0 | $0 | $3 | $0 |
| G&A Expenses | $12 | $11 | $8 | $9 |
| SG&A Expenses | $12 | $11 | $8 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1 | -$10 | -$2 | -$0 |
| Operating Expenses | $13 | $1 | $8 | $10 |
| Operating Income | -$12 | -$15 | -$9 | -$9 |
| % Margin | -524.8% | -957.8% | -566.3% | -419.2% |
| Other Income/Exp. Net | -$3 | -$0 | $1 | -$0 |
| Pre-Tax Income | -$15 | -$16 | -$10 | -$9 |
| Tax Expense | $0 | $0 | -$0 | -$0 |
| Net Income | -$15 | -$16 | -$11 | -$9 |
| % Margin | -673.8% | -980.1% | -674.9% | -428.1% |
| EPS | -0.055 | -0.056 | -0.042 | -0.035 |
| % Growth | 1.3% | -33.6% | -19.8% | – |
| EPS Diluted | -0.055 | -0.056 | -0.042 | -0.035 |
| Weighted Avg Shares Out | 280 | 281 | 270 | 252 |
| Weighted Avg Shares Out Dil | 280 | 279 | 270 | 252 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$12 | -$14 | -$8 | -$6 |
| % Margin | -523.5% | -873.3% | -462% | -310.7% |